D. E. Shaw & Co., Inc. Denali Therapeutics Inc. Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 116,265 shares of DNLI stock, worth $2.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,265

Holding current value

$2.46 Million

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$15.83 - $23.35 $1.84 Million - $2.71 Million	116,265 New	116,265 $2.39 Million
Q1 2023 May 15, 2023	SELL	$21.91 - $32.67 $1.97 Million - $2.94 Million	-90,091 Reduced 67.02%	44,336 $1.02 Million
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $3.53 Million - $4.56 Million	134,427 New	134,427 $3.74 Million
Q2 2022 Aug 15, 2022	BUY	$20.88 - $35.19 $1.67 Million - $2.81 Million	79,865 Added 1278.25%	86,113 $2.53 Million
Q1 2022 May 16, 2022	SELL	$29.0 - $47.27 $28,652 - $46,702	-988 Reduced 13.65%	6,248 $201,000

Q4 2021 Feb 14, 2022	SELL	$42.59 - $55.02 $1.63 Million - $2.1 Million	-38,177 Reduced 84.07%	7,236 $323,000
Q3 2021 Nov 15, 2021	SELL	$48.48 - $78.23 $1.85 Million - $2.99 Million	-38,172 Reduced 45.67%	45,413 $2.29 Million
Q2 2021 Aug 16, 2021	SELL	$50.3 - $78.44 $6.17 Million - $9.61 Million	-122,577 Reduced 59.46%	83,585 $6.56 Million
Q1 2021 May 17, 2021	BUY	$53.8 - $81.53 $6.82 Million - $10.3 Million	126,802 Added 159.78%	206,162 $11.8 Million
Q4 2020 Feb 16, 2021	SELL	$36.89 - $93.56 $2.42 Million - $6.14 Million	-65,658 Reduced 45.28%	79,360 $6.65 Million
Q3 2020 Nov 16, 2020	BUY	$23.13 - $38.84 $3.35 Million - $5.63 Million	145,018 New	145,018 $5.2 Million
Q3 2019 Nov 14, 2019	SELL	$15.32 - $21.92 $1.57 Million - $2.24 Million	-102,274 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.5 - $28.14 $1.89 Million - $2.88 Million	102,274 New	102,274 $2.12 Million

Others Institutions Holding DNLI

# of Institutions

217

Shares Held

115M

Call Options Held

142K

Put Options Held

90.3K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.84B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account